Antidepressant- and anxiolytic effects of the novel melatonin agonist Neu-P11 in rodent models

被引：0
|
作者：
Shao-wen Tian
Moshe Laudon
Li Han
Jun Gao
Fu-lian Huang
Yu-feng Yang
Hai-feng Deng
机构：
[1] Medical School,Department of Physiology
[2] University of South China,Department of Physiology
[3] Neurim Pharmaceuticals Ltd,undefined
[4] Changsha Medical University,undefined
来源：
Acta Pharmacologica Sinica | 2010年 / 31卷
关键词：
melatonin; Neu-P11; antidepressant; anxiolytic; sleep disorders; stress-related illnesses; learned helplessness; forced swimming test; elevated plus-maze;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：775 / 783
页数：8
相关论文
共 43 条
  • [21] The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel κ agonist and μ partial agonist, in mice
    Qian Wang
    Yu Long
    Ai Hang
    Gui-Ying Zan
    Xiao-Hong Shu
    Yu-Jun Wang
    Jing-Gen Liu
    Psychopharmacology, 2016, 233 : 2411 - 2418
  • [22] The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel κ agonist and μ partial agonist, in mice
    Wang, Qian
    Long, Yu
    Hang, Ai
    Zan, Gui-Ying
    Shu, Xiao-Hong
    Wang, Yu-Jun
    Liu, Jing-Gen
    PSYCHOPHARMACOLOGY, 2016, 233 (12) : 2411 - 2418
  • [23] Neu-P11, a novel MT1/MT2 agonist, reverses diabetes by suppressing the hypothalamic-pituitary-adrenal axis in rats
    Zhou, Jun
    Zhang, Jin
    Luo, XiaoHong
    Li, MaoXing
    Yue, Ying
    Laudon, Moshe
    Jia, ZhengPing
    Zhang, RuXue
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 812 : 225 - 233
  • [24] Neu-P11-a novel melatonin receptor agonist, could improve the features of type-2 diabetes mellitus in rats
    Li, Xiuping
    He, Juan
    Li, Xing
    Li, Yuxian
    Zhou, Yang
    Cai, Shichang
    ENDOKRYNOLOGIA POLSKA, 2021, 72 (06) : 634 - 642
  • [25] Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT1A and 5-HT7 Antagonists in Animal Models
    Pytka, Karolina
    Partyka, Anna
    Jastrzebska-Wiesek, Magdalena
    Siwek, Agata
    Gluch-Lutwin, Monika
    Mordyl, Barbara
    Kazek, Grzegorz
    Rapacz, Anna
    Olczyk, Adrian
    Galuszka, Adam
    Blachuta, Marian
    Waszkielewicz, Anna
    Marona, Henryk
    Sepa, Jacek
    Filipek, Barbara
    Wesolowska, Anna
    PLOS ONE, 2015, 10 (11):
  • [26] Neu-P11: a novel drug for the treatment of insomnia and central sensitivity syndrome symptoms - results of a Phase-Ib study
    Katz, A.
    Metzger, D.
    Staner, L.
    Pross, N.
    Cornette, F.
    Guichard, N.
    Laudon, M.
    Nir, T.
    Zisapel, N.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S220 - S221
  • [27] BEHAVIORAL-EFFECTS OF AHR-14042, A NOVEL AZETIDINE ANXIOLYTIC, IN RODENT MODELS OF ANXIETY
    BILL, DJ
    CRONIN, S
    GREWAL, SS
    MCNICOLL, C
    FLETCHER, A
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 : P125 - P125
  • [28] Antidepressant and anxiolytic-like effects of 4n, a novel 5-HT3 receptor antagonist using behaviour based rodent models
    Kumar, Baldev
    Jindal, Ankur
    Pandey, Dilip Kumar
    Bhatt, Shvetank
    Devadoss, Thangaraj
    Mahesh, Radhakrishnan
    INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, 2012, 50 (09) : 625 - 632
  • [29] Potent antidiabetic effects of rivoglitazone, a novel PPARγ agonist, in obese diabetic rodent models
    Ohsumi, J.
    Kanda, S.
    Tanaka, J.
    Takahashi, K.
    Nakashima, R.
    Koieyama, N.
    Hagisawa, Y.
    Araki, K.
    DIABETOLOGIA, 2007, 50 : S353 - S353
  • [30] YL-0919, a dual 5-HT1A partial agonist and SSRI, produces antidepressant- and anxiolytic-like effects in rats subjected to chronic unpredictable stress
    Yu-hua Ran
    Xiao-xu Hu
    Yu-lu Wang
    Nan Zhao
    Li-ming Zhang
    Hua-xia Liu
    Yun-feng Li
    Acta Pharmacologica Sinica, 2018, 39 : 12 - 23
12345